Latest papers

Characterizing stiffness of human prostates using acoustic radiation force.

[Detection of prostate cancer. German guideline recommends opportunist screening].

The novel nomogram of Gleason sum upgrade: possible application for the eligible criteria of low dose rate brachytherapy.

Technique for a hybrid system of real-time transrectal ultrasound with preoperative magnetic resonance imaging in the guidance of targeted prostate biopsy.

A coupled global registration and segmentation framework with application to magnetic resonance prostate imagery.

Antagonism of estrogen-mediated cell proliferation by raloxifene in prevention of ageing-related prostatic hyperplasia.

Technical note: calculation of normal tissue complication probability using Gaussian error function model.

The accuracy and safety aspects of a novel robotic needle guide manipulator to perform transrectal prostate biopsies.

ERβ: recent understanding of estrogen signaling

Dutasteride and prostate cancer.

Dutasteride and prostate cancer.

Identification of a cell of origin for human prostate cancer.

Conventional monopolar resection or bipolar resection in saline for the management of large (>60 g) benign prostatic hyperplasia: an evaluation of morbidity.

[Bacterial 16S rRNA genes and expression of IL-1β, TNF-α and IgA in prostate tissues].

Magnetic resonance imaging-defined treatment margins in iodine-125 prostate brachytherapy.

Stability, visibility, and histologic analysis of a new implanted fiducial for use as a kilovoltage radiographic or radioactive marker for patient positioning and monitoring in radiotherapy.

A comparison of in-room computerized tomography options for detection of fiducial markers in prostate cancer radiotherapy.

A cinematic magnetic resonance imaging study of milk of magnesia laxative and an antiflatulent diet to reduce intrafraction prostate motion.

Prostate localization on daily cone-beam computed tomography images: accuracy assessment of similarity metrics.

Siah2-Dependent Concerted Activity of HIF and FoxA2 Regulates Formation of Neuroendocrine Phenotype and Neuroendocrine Prostate Tumors